ACHN

Achillion Pharmaceuticals, Inc. News Headlines

$12.49
*  
0.15
1.19%
Get ACHN Alerts
*Delayed - data as of Feb. 26, 2015  -  Find a broker to begin trading ACHN now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    ACHN After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Hep C Franchise Will Remain Key Midterm Driver For Gilead
2/17/2015 1:34:00 PM - Seeking Alpha


Achillion Pharmaceuticals: A Strong Contender In A Crowded Space
2/17/2015 8:53:00 AM - Seeking Alpha


Achillion Pharmaceuticals: High Marketing Potential With Long-Term Prospects
2/14/2015 10:37:00 AM - Seeking Alpha


Seeking Alpha's Biotech Weekly: Crush-Proof Pfizer, Achillion's HCV Crusher, And More
2/13/2015 4:00:00 PM - Seeking Alpha


Achillion Prices Public Offering Of 12 Mln Common Shares At $10.25 Per Share
2/12/2015 12:07:00 AM - RTT News


Baxter Needs To Split Up - Cramer's Lightning Round (2/10/15)
2/11/2015 5:28:00 AM - Seeking Alpha


Jim Cramer Answers Twitter Questions on Coca-Cola, Yelp, Facebook, and More
2/9/2015 3:21:00 PM - TheStreet


Achillion Shares Rise, Regulus Falls After Hepatitis C Results
2/9/2015 1:55:00 PM - Dow Jones Business News


Achillion HCV-1 regimen achieves 100% SVR12 at six weeks
2/9/2015 7:34:00 AM - Seeking Alpha


Stay Away From Martin Midstream - Cramer's Lightning Round (1/27/15)
1/28/2015 5:48:00 AM - Seeking Alpha


How To Play Gilead In 2015: It's Going To Be A Bumpy Ride
1/16/2015 1:45:00 PM - Seeking Alpha


I'm Expecting Some Very Positive News Flow From Gilead
1/12/2015 11:55:00 AM - Seeking Alpha


3 Biotech Stocks That Soared Past Gilead in 2014 - Analyst Blog
12/30/2014 10:41:00 AM - Investopedia


DoctoRx Positions For 2015: I Have Cut Back On My Exposure To All Biotech Substantially
12/30/2014 7:05:00 AM - Seeking Alpha


Seeking Alpha's Biotech Weekly: AbbVie Slaps Gilead, Achillion's 'Nuc' Power, And More
12/26/2014 4:00:00 PM - Seeking Alpha


Biotech Stock Roundup: AbbVie's HCV Treatment Approved, ImmunoGen Plunges on Data - Analyst Blog
12/24/2014 9:48:00 AM - Investopedia


Achillion Gains on Positive Results from its HCV Candidates - Analyst Blog
12/23/2014 5:00:00 AM - Investopedia


Stocks Turning In A Lackluster Performance In Mid-Day Trading - U.S. Commentary
12/22/2014 12:08:00 PM - RTT News


Today's Market: Hepatitis C News Moving These Stocks
12/22/2014 10:39:00 AM - Seeking Alpha


Stocks Move Modestly Higher, Extending Upward Trend - U.S. Commentary
12/22/2014 10:33:00 AM - RTT News


Sovaldi Can't Sustain The Current Prices Of Gilead Sciences' Stock: Algorithmic And Fundamental Analysis
12/12/2014 3:27:00 PM - Seeking Alpha


Achillion Pharmaceuticals To Present In Piper Jaffray Conference At 11:30 AM ET
12/3/2014 10:33:00 AM - RTT News


Achillion Pharma. To Present At Deutsche Bank BioFEST ; Webcast At 9:15 AM ET
12/1/2014 8:17:00 AM - RTT News


Regulus To See Further Declines
11/19/2014 12:21:00 PM - Seeking Alpha


Regulus To See Further Declines
11/19/2014 10:30:00 AM - Seeking Alpha